V2X Inc (NYSE:VVX) stock is brushing off the broad market selloff today, after the defense name secured a $170 million contract with the Drug Enforcement Administration (DEA). At last check, VVX is up 0.3% to trade at $47.11, one of the few positive names on the New York Stock Exchange (NYSE) today.The stock earlier traded as high as $47.87, but succumbed to broad market headwinds. Regardless, the gains today have VVX holding its year-to-date and year-over-year breakeven levels. The shares are stumbling int ...